Product Information

ZONISAMIDE 50 MG CAPSULE is a generic product labeled by Exelan Pharmaceuticals Inc., priced at $0.0982 per EA under NDC 76282022701. Its NADAC has been published 189 times since Jan 11, 2023.

FDA first approved this application on May 31, 2006. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

ZONISAMIDE 50 MG CAPSULE

Zonisamide
$0.0982per EA

Strength

50 mg/1

NDC

76282022701

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

ZONISAMIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA077869

FDA Approved

5/31/2006

TE Code

AB

On Market Since

3/15/2021

Pharmacological Classes

Anti-epileptic Agent
Carbonic Anhydrase Inhibitors
Decreased Central Nervous System Disorganized Electrical Activity
P-Glycoprotein Inhibitors
Sulfonamides

Price Statistics

The NADAC for ZONISAMIDE 50 MG CAPSULE has been published 189 times since Jan 11, 2023, and over the history we have for it it has risen 7.3%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0982 per EA
All-time high$0.1181 (Sep 13, 2023)
All-time low$0.0679 (Jul 17, 2024)
52-week high$0.0984
52-week low$0.0948
Median price$0.0951
Average price$0.0925
Largest weekly change+39.5% (Aug 21, 2024)
Weeks tracked189
Tracking sinceJan 11, 2023

Price History

1W

+3.6%

1M

+3.6%

3M

+1.1%

6M

+0.9%

1Y

+2.7%

3Y

-0.0%

5Y

N/A

All

+7.3%

Generic Alternatives

The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 1% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of ZONISAMIDE 50 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for ZONISAMIDE 50 MG CAPSULE, manufactured by Exelan Pharmaceuticals Inc., is $0.0982 per EA (NDC 76282022701), effective Aug 19, 2026.

How has the price of ZONISAMIDE 50 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for ZONISAMIDE 50 MG CAPSULE has risen 7.3%. It has been tracked across 189 weekly CMS publications since Jan 11, 2023.

What are the highest and lowest recorded NADAC prices for ZONISAMIDE 50 MG CAPSULE?

Since Jan 11, 2023, the NADAC for ZONISAMIDE 50 MG CAPSULE has ranged from a low of $0.0679 (Jul 17, 2024) to a high of $0.1181 (Sep 13, 2023), with a median of $0.0951 per EA.

Are there cheaper alternatives to ZONISAMIDE 50 MG CAPSULE?

Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ZONISAMIDE 50 MG CAPSULE, is $0.0974 per EA — about 1% below ZONISAMIDE 50 MG CAPSULE.

Who manufactures ZONISAMIDE 50 MG CAPSULE?

ZONISAMIDE 50 MG CAPSULE (NDC 76282022701) is labeled by Exelan Pharmaceuticals Inc., and CMS classifies it as a generic product.